Astrana Health, Inc. (NASDAQ:ASTH) Receives $45.00 Average Price Target from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been given a consensus recommendation of “Moderate Buy” by the nine analysts that are presently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $45.00.

A number of research firms recently weighed in on ASTH. Weiss Ratings raised shares of Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 1st. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 11th. Robert W. Baird set a $45.00 price objective on shares of Astrana Health in a research note on Friday, May 8th. BTIG Research reaffirmed a “buy” rating and set a $50.00 target price on shares of Astrana Health in a report on Tuesday, June 2nd. Finally, Barclays upgraded shares of Astrana Health from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $37.00 to $50.00 in a research report on Tuesday, May 26th.

Institutional Investors Weigh In On Astrana Health

A number of institutional investors have recently made changes to their positions in the stock. Signaturefd LLC grew its position in shares of Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the period. GAMMA Investing LLC lifted its stake in Astrana Health by 144.7% in the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after buying an additional 871 shares in the last quarter. Strs Ohio bought a new position in Astrana Health in the fourth quarter valued at approximately $40,000. Tower Research Capital LLC TRC boosted its holdings in shares of Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after buying an additional 3,517 shares during the period. Finally, State of Wyoming acquired a new position in shares of Astrana Health in the second quarter valued at approximately $132,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Trading Up 0.8%

ASTH stock traded up $0.38 during midday trading on Tuesday, reaching $47.29. The stock had a trading volume of 149,665 shares, compared to its average volume of 551,341. The business has a fifty day simple moving average of $39.34 and a two-hundred day simple moving average of $29.87. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 1.20. The firm has a market cap of $2.64 billion, a price-to-earnings ratio of 77.59 and a beta of 0.89. Astrana Health has a twelve month low of $18.08 and a twelve month high of $51.60.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.45. The firm had revenue of $965.10 million during the quarter, compared to analysts’ expectations of $949.21 million. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The company’s quarterly revenue was up 55.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.42 EPS. As a group, research analysts expect that Astrana Health will post 1.25 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.